Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Change in Receivables: 2018-2024

Historic Change in Receivables for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$28.1 million.

  • Arcturus Therapeutics Holdings' Change in Receivables fell 251.34% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.2 million, marking a year-over-year decrease of 177.37%. This contributed to the annual value of -$28.1 million for FY2024, which is 195.87% down from last year.
  • Per Arcturus Therapeutics Holdings' latest filing, its Change in Receivables stood at -$28.1 million for FY2024, which was down 195.87% from $29.3 million recorded in FY2023.
  • Arcturus Therapeutics Holdings' 5-year Change in Receivables high stood at $29.3 million for FY2023, and its period low was -$28.1 million during FY2024.
  • For the 3-year period, Arcturus Therapeutics Holdings' Change in Receivables averaged around $202,333, with its median value being -$603,000 (2022).
  • Per our database at Business Quant, Arcturus Therapeutics Holdings' Change in Receivables skyrocketed by 4,959.04% in 2023 and then crashed by 195.87% in 2024.
  • Yearly analysis of 5 years shows Arcturus Therapeutics Holdings' Change in Receivables stood at -$54,000 in 2020, then spiked by 2,400.00% to $1.2 million in 2021, then tumbled by 148.55% to -$603,000 in 2022, then soared by 4,959.04% to $29.3 million in 2023, then plummeted by 195.87% to -$28.1 million in 2024.